[What has changed in therapy of vascular patients (role of statins and beta-adrenoblockers)].

Systematised herein are the results of large-scale randomized studies, as well as own findings regarding the use of beta-adrenoblockers and statins in vascular patients. Administration of selective beta-adrenoblockers and statins appeared to decrease the cardiac-complication rate in this cohort of patients.